James Stewart puts on his rollerblades to get ready to do the trail in Rabb Park on his day off. He continues to be able to ...

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of ...

US surgeons successfully performed the world's first human bladder transplant on 4 May 2025. The complicated, eight-hour procedure involved the retrieval of a kidney and bladder from an organ donor ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its ...

Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an immunotherapy drug called durvalumab, research has shown. Jörg ...

In-hospital deaths among patients hospitalized with bladder cancer in the United States increased from 2008 to 2021, suggesting more work needs to be done to prevent early death in this patient ...

rBCG offers an alternative to TICE® BCG amid U.S. shortages, impacting bladder cancer treatment availability. FDA's Expanded Access Program allows investigational rBCG use when no satisfactory ...

Researchers have found in a Finnish population-based cohort study that diabetes and poor glycemic status were associated with ...

Scientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a host immune system enzyme that attacks DNA.